{"id":919845,"date":"2026-10-04T03:48:23","date_gmt":"2026-10-04T03:48:23","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/919845\/"},"modified":"2026-10-04T03:48:23","modified_gmt":"2026-10-04T03:48:23","slug":"easd26-lillys-amylin-zepbound-combo-posts-best-ever-weight-loss-in-patients-with-obesity-and-diabetes-endpoints-news","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/919845\/","title":{"rendered":"#EASD26: Lilly\u2019s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes &#8211; Endpoints News"},"content":{"rendered":"<p><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiwwFBVV95cUxNSFB0dlM2UDRfMzBjamdldzJScHlCZTRfcTdlaWd4ckRMTzR2Mm1oeWpCRUxyTFNwRVlsLXVRNVJkRmtzWU9qUXF4MG1HT01aekFqOE1pcS1IOTVQQUt4dU5YQ3BZTTcyQmR0cU40RnY1LUg5T2UwVXRZekhneHhZS1drbGNzckRIVVRQWlBTaXJYTTctRHJNM0tuSVdQNTNwZmh6b0RtQjM2dHBXV2Rxam9HcVFtQUkybEoyY19RdDRKdzQ?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">#EASD26: Lilly\u2019s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes<\/a>&nbsp;&nbsp;Endpoints News<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiggFBVV95cUxNeUwxRnhCemVwSGUzc015aUFwQWt5YmZkZzJRUV84U05HTTlUbzlGazQ3ckM1SHM5TFV0VDJ1RnVFcnNPUWZJVjNLa01YS29DNjJacXlPclZFWG9TTDdWMzZGZjR1MWkxN0Y3WDJJQ1FzVDFPM1ppX21mdlV5Vl9uXzJ3?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Eli Lilly obesity drug data adds pressure on Novo Nordisk<\/a>&nbsp;&nbsp;Yahoo! Finance Canada<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMid0FVX3lxTE9nLU5qVURCR0h4SmxQUjdDYXdPYUtUa3VzUzdGM3d1MWlEY1JldnpuekktRkFUOHVBbTZtM3BEQWVrNmg3U1J0TVdUSmp5Zmg0ZXZLSWZXTm1udlBxak9QaDMxV2h1QlJybXVnS3NJYjJUdHNBZnlv0gF8QVVfeXFMTWVtbmp4Rmx2aWF1ZFVheklrLVhPdV9KYUlNUTR1NDM0U3kyQndmcVQyWnV5VTdEU29aRmgtMFpJbWc4RUZSWmlOZV9kb3d4M3I1Z01CdVNSQkx0ZHJpekEySUR5OTA3V2pjZzJrVFN4Ql9IVkoyNFhmMHlSSA?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s<\/a>&nbsp;&nbsp;CNBC<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMioAFBVV95cUxQbEtYS3k2bDJybHh0ZmxDVm9LOElUellCeGtNYjBSZW4yZGtueGJWb0Rrc2xodmswdkdnOFllWEVTNjhJRkpVRWx0RkdFcl96OG41R0FyenRMUnM0RW5DOXNSSk9rbzZwVGFhLVQ2TkIwamdsYmNjU0tiVDE3YV9RS29JMFA0WjdpTGhEWDJBNGU4VkhNZXlQeFM3cjZaMFRW?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Ozempic Rival Delivers 25% Weight Loss at Highest Dose in Phase 3 Trial<\/a>&nbsp;&nbsp;ScienceAlert<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiwwFBVV95cUxOb25xR3djUTZrOHZrOWc3em9vZ0IxRU51R1I5M2xoVUZBdXlYVnZCOEEtOUpNUnBSOWdiWnRyTzJlT1ZBV0JqRkl1cUtPZjBzclhISEhrZ25SRFlVVTQyVzNMRnVfYzNqeHVMWjloU1o0NzZNTTJ4T2tqaVIxVlpRU3R1Vkt1c3VYcl9GRWVOODIzaHM0bUdNYkVGcXpfSHBaWnd0blRxb2FMYUc2Vi01Qnk5dXVZREZkMnZDTFNpSEVtdlE?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Blockbuster retatrutide trial signals a \u2018new high-water mark\u2019 for weight-loss drugs<\/a>&nbsp;&nbsp;Scientific American<\/p>\n","protected":false},"excerpt":{"rendered":"#EASD26: Lilly\u2019s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes&nbsp;&nbsp;Endpoints NewsEli Lilly obesity drug&hellip;\n","protected":false},"author":2,"featured_media":919846,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[49,316789,48,316790,316791,84,80121,377,1229,66764,106041,13666,3379,953,78031],"class_list":["post-919845","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-ca","tag-cagrisema","tag-canada","tag-eloralintide","tag-eloratzp","tag-health","tag-lilly","tag-medication","tag-obesity","tag-rd","tag-retatrutide","tag-tirzepatide","tag-type-2-diabetes","tag-weight-loss","tag-zepbound"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/919845","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=919845"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/919845\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/919846"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=919845"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=919845"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=919845"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}